General Range
FORDOXIME-CV
Price on request/100 · MOQ 100 boxes
FORDOXIME-CV Tablets by Fortune Labs contain Cefpodoxime Proxetil and Potassium Clavulanate, an antibiotic combination formulated for treating selected bacterial infections. Cefpodoxime Proxetil is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Potassium Clavulanate helps protect the antibiotic against certain bacterial beta-lactamase enzymes. This combination may be prescribed for susceptible respiratory tract, urinary tract, ear, and skin infections when clinically appropriate. FORDOXIME-CV comes in convenient 10 × 10 tablet blister packaging. Fortune Labs offers this formulation to authorized pharmaceutical distributors and PCD Pharma Franchise partners across India. Contact Fortune Labs for wholesale pricing, product availability, franchise opportunities, and distribution enquiries. Use only as prescribed by a healthcare professional.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Cefpodoxime Proxetil + Potassium Clavulanate Tablets
- Packaging Type
- Blister Pack
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Bacterial respiratory tract infections, throat infections, sinusitis, ear infections, urinary tract infections, and certain skin infections when presc
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
